Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study H Jensen, ML Tørring, F Olesen, J Overgaard, P Vedsted BMC cancer 14, 1-11, 2014 | 156 | 2014 |
Diagnostic intervals before and after implementation of cancer patient pathways–a GP survey and registry based comparison of three cohorts of cancer patients H Jensen, ML Tørring, F Olesen, J Overgaard, M Fenger-Grøn, P Vedsted BMC cancer 15, 1-10, 2015 | 96 | 2015 |
Rural–urban disparities in time to diagnosis and treatment for colorectal and breast cancer RJ Bergin, J Emery, RC Bollard, AZ Falborg, H Jensen, D Weller, ... Cancer Epidemiology, Biomarkers & Prevention 27 (9), 1036-1046, 2018 | 70 | 2018 |
Advanced‐stage cancer and time to diagnosis: an international cancer benchmarking partnership (ICBP) cross‐sectional study ML Tørring, AZ Falborg, H Jensen, RD Neal, D Weller, I Reguilon, ... European Journal of Cancer Care 28 (5), e13100, 2019 | 60 | 2019 |
Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer … D Weller, U Menon, AZ Falborg, H Jensen, A Barisic, AK Knudsen, ... BMJ open 8 (11), e023870, 2018 | 57 | 2018 |
Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care H Jensen, ML Tørring, P Vedsted BMC cancer 17, 1-10, 2017 | 54 | 2017 |
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and … D Weller, P Vedsted, C Anandan, A Zalounina, EO Fourkala, R Desai, ... BMJ open 6 (7), e009641, 2016 | 44 | 2016 |
Quality deviations in cancer diagnosis: prevalence and time to diagnosis in general practice H Jensen, A Nissen, P Vedsted British Journal of General Practice 64 (619), e92-e98, 2014 | 43 | 2014 |
Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines G Funston, M Van Melle, MLL Baun, H Jensen, C Helsper, J Emery, ... BMC cancer 19, 1-13, 2019 | 35 | 2019 |
The effect of standardised cancer pathways on Danish cancer patients' dissatisfaction with waiting time TL Dahl, P Vedsted, H Jensen Dan Med J 64 (1), A5322, 2017 | 34 | 2017 |
The role of general practice in routes to diagnosis of lung cancer in Denmark: a population-based study of general practice involvement, diagnostic activity and diagnostic … LM Guldbrandt, M Fenger-Grøn, TR Rasmussen, H Jensen, P Vedsted BMC Health Services Research 15, 1-10, 2015 | 32 | 2015 |
Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort H Jensen, ML Tørring, MB Larsen, P Vedsted Clinical Epidemiology, 237-246, 2014 | 32 | 2014 |
A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial H Jensen, H Svanholm, H Stoevring, F Bro Journal of Epidemiology & Community Health 63 (7), 510-515, 2009 | 32 | 2009 |
Identification of patients with incident cancers using administrative registry data MB Larsen, H Jensen, RP Hansen, F Olesen, P Vedsted Dan Med J 61 (2), A4777, 2014 | 27 | 2014 |
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP) U Menon, P Vedsted, AZ Falborg, H Jensen, S Harrison, I Reguilon, ... BMJ open 9 (11), e025895, 2019 | 26 | 2019 |
Consultation frequency in general practice before cancer diagnosis in relation to the patient’s usual consultation pattern: a population-based study H Jensen, P Vedsted, H Møller Cancer epidemiology 55, 142-148, 2018 | 25 | 2018 |
Current organisation of follow-up does not meet cancer patients' needs C Sperling, M Sandager, H Jensen, JL Knudsen Dan Med J 61 (6), A4855, 2014 | 22 | 2014 |
Cancer patients’ experiences with urgent referrals to cancer patient pathways M Sandager, H Jensen, H Lipczak, CD Sperling, P Vedsted European journal of cancer care 28 (1), e12927, 2019 | 20 | 2019 |
Time from incident primary cancer until recurrence or second primary cancer: risk factors and impact in general practice LA Rasmussen, H Jensen, LF Virgilsen, AZ Falborg, H Møller, P Vedsted European journal of cancer care 28 (5), e13123, 2019 | 19 | 2019 |
Exploration of the possible effect on survival of lead-time associated with implementation of cancer patient pathways among symptomatic first-time cancer patients in Denmark H Jensen, P Vedsted Cancer epidemiology 49, 195-201, 2017 | 19 | 2017 |